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Structural and computational biology play key roles in elucidating molecular 
mechanisms of disease phenotypes and in driving drug discovery. This is 
exemplified by the current fast-paced efforts to respond to the COVID-19 
pandemic. To aid these endeavors, the University of Bristol set up a COVID 
Emergency group (UNCOVER), coordinated by Bristol clinician Adam Finn, that 
initiated multi-disciplinary collaborations among virologists, chemists, physicians, 
pharmacologists and others to accelerate our understanding of COVID-19 and to 
design tailored treatments urgently needed to overcome the crisis. In our 
contribution, we discovered a druggable pocket in the SARS-CoV-2 spike (S) 
glycoprotein, the viral component that mediates interaction with the cellular ACE2 
receptor and that is essential for infection [1]. In our cryo-EM structure of S, this 
pocket was occupied by linoleic acid (LA), an essential poly-unsaturated free 
fatty acid (FFA). LA stabilized S in a locked conformation that is incompatible 
with ACE2 binding and is thus considered ‘non-infective’. Intriguingly, LA 
synergizes with remdesivir, the first drug approved for COVID-19 treatment, to 
block viral replication in cells [1]. Our discovery has actionable implications: the 
data suggest that LA could act as a prophylactic antiviral. Intriguingly, sera of 
COVID-19 patients have decreased levels of FFAs, including LA [2]; therefore LA 
supplementation may be beneficial. Small molecules binding the FFA-binding 
pocket (LA mimics) have potential as future antivirals as they might lock S in a 
non-infective conformation. Finally, tThe body metabolizes LA to eicosanoids, 
including prostaglandin, key molecules in immune modulation. In addition, LA-
based phospholipids maintain fluidity of cell membranes and surface tension in 
the lung. While more research is required to decipher the interplay of FFAs, 
SARS-CoV-2 and COVID-19 pathologyThus, targeting the LA metabolic axis 
could help prevent rampant inflammatory responses in severe cases of COVID-
19 and reduce respiratory distress and the risk of pneumonia in patients. Finally, 
LA mimics have potential as future small-molecule antivirals as they might lock S 
in a non-infective conformation.. While more research is required to decipher the 
interplay of FFA, SARS-CoV-2 and COVID-19 pathology, our research provides 
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Commented [AS1]: Moved up, because I think the 
transition to LA supplementation works very well, while 
the pocket-binding drugs cover another aspect of the 
work. 
Commented [CB2R1]: I agree, it works well this way. 
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